Fulltext
full text is available in PDF.
e-ISSN 2383-1960
p-ISSN 2383-1979
Image Credit:Ann Mil Health Sci Res
Outline
Studying a specific tumor marker by a new method and analyzing its efficiency in labeling animals
Authors
1Department of Radiation Technology, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Andorra
2Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran., Andorra
*Corresponding Author: Corresponding author: Zhila Jamshidinia, Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran., Andorra Email: zhi_jam@yahoo.com
Published online:Mar 18, 2015
Article type:Research Article
Received:Dec 17, 2014
Accepted:Feb 20, 2015
How to Cite: Navabpour M, Jamshidinia Z, Bakhshandeh M. Studying a specific tumor marker by a new method and analyzing its efficiency in labeling animals. Ann Mil Health Sci Res. 2015;13(1):e62660. doi:
Abstract
Materials and Methods: Since uptake of gallium by liver has been reported in numerous researches, it was bonded with a contrast media (metrizoate). X-ray imaging was done to determine geometric features of liver.
Results: Radiographic image was obtained. Maximum contrast in radiographic image was observed 72 hours after injection. In addition, increase of effective tumor atomic number caused by metrizoate helped the tumor to be treated by a smart radiotherapy method (i.e. photoelectron therapy). It increased photoelectron therapy efficiency up to two thousand percentages.
Conclusion: A new method of killing cancer cells can be developed using contrast agents. Also, metrizoate-labeled gallium is recommended for marking animals
Highlights
References
- 1.References is available in PDF.
Copyright
© 2015, Annals of Military and Health Sciences Research. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
6
Nov
2013
Determination of Maximum Transmission Time of the Labeled Complex to Malignant Lymphatic Cells Using Cell Culture
Naeima Navvabpour,
Mojtaba Navabbpour,
Zhila Jamshidinia
Navvabpour N, Navabbpour M, Jamshidinia Z. Determination of Maximum Transmission Time of the Labeled Complex to Malignant Lymphatic Cells Using Cell Culture. Ann Mil Health Sci Res. 2013;11(4):e64705. doi:
30
Apr
2012
Preparation and Biodistribution Studies of a Radiogallium-Acetylacetonate Bis (Thiosemicarbazone) Complex in Tumor-Bearing Rodents
Amir Reza Jalilian,
Hassan Yousefnia,
Kamaleddin Shafaii,
Aytak Novinrouz,
Amir Abbas Rajamand
Jalilian AR, Yousefnia H, Shafaii K, Novinrouz A, Rajamand AA. Preparation and Biodistribution Studies of a Radiogallium-Acetylacetonate Bis (Thiosemicarbazone) Complex in Tumor-Bearing Rodents. Iran J Pharm Res. 2012;11(2):e125870. doi: https://doi.org/10.22037/ijpr.2012.1090
31
Jul
2012
Development of Ga-67 Maltolate Complex as an Imaging Agent
Yousef Fazaeli,
Amir Reza Jalilian,
Mostafa Mohammadpour Amini,
Abbas Majdabadi,
Ali Rahiminejad,
Fatemeh Bolourinovin
,et al.Fazaeli Y, Jalilian AR, Mohammadpour Amini M, Majdabadi A, Rahiminejad A, et al. Development of Ga-67 Maltolate Complex as an Imaging Agent. Iran J Pharm Res. 2012;11(3):e125826. doi: https://doi.org/10.22037/ijpr.2012.1114
31
Oct
2017
Preclinical Evaluation of 68Ga-MAA from Commercial Available 99mTc-MAA Kit
Saeed Shanehsazzadeh,
Amir Reza Jalilian,
Afsaneh Lahooti,
Parham Geramifar,
Davood Beiki,
Hassan Yousefnia
,et al.Shanehsazzadeh S, Jalilian AR, Lahooti A, Geramifar P, Beiki D, et al. Preclinical Evaluation of 68Ga-MAA from Commercial Available 99mTc-MAA Kit. Iran J Pharm Res. 2017;16(4):e125048. doi: https://doi.org/10.22037/ijpr.2017.2121
31
Jul
2017
Evaluation of a 99mTc-tricine Vascular Disrupting Agent as an In-vivo Imaging in 4T1 Mouse Breast Tumor Model
Mostafa Erfani,
Seyed Pezhman Shirmardi,
Mohammad Shafiei
Erfani M, Shirmardi SP, Shafiei M. Evaluation of a 99mTc-tricine Vascular Disrupting Agent as an In-vivo Imaging in 4T1 Mouse Breast Tumor Model. Iran J Pharm Res. 2017;16(3):e124960. doi: https://doi.org/10.22037/ijpr.2017.2094
More by these authors
Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 8 hours ago
- OpenAlex: 0
Last Update: 12 hours ago
- OpenCitations: 0
Last Update: 5 days ago
Comments
Number of Comments:0